SCHEMBL18100336

SCHEMBL18100336

CCO/C(=N\c1ccc(S(=O)(=O)c2ccc(/N=C(\OCC)c3ccccc3)cc2)cc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PRMT1 Q99873 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18100334 0.85 RAB9A (0.42) GAAL3MBTL1RAB9AALDH1A1HPGD
SCHEMBL18100348 0.84 KMT2A (0.45) L3MBTL1RAB9AALDH1A1CHRM2CHRM1
SCHEMBL18100430 0.83 PRMT1 (0.45) GAAL3MBTL1RAB9AHPGDPOLB
SCHEMBL18100341 0.83 PRMT1 (0.45) GAAL3MBTL1RAB9AHPGDPOLB
SCHEMBL18100322 0.83 ALDH1A1 (0.43) GAAL3MBTL1ALDH1A1MAPTSMN1; SMN2
SCHEMBL22808570 0.81 ESR1 (0.44) GAAALDH1A1CHRM1MAPTCA12
SCHEMBL18100343 0.80 NOS3 (0.50) RAB9AALDH1A1HPGDMAPTHTT
SCHEMBL18100333 0.80 SLC22A2 (0.49) GAAALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL18100355 0.79 RAB9A (0.45) GAAL3MBTL1RAB9AALDH1A1HPGD
SCHEMBL11564425 0.77 NOS3 (0.46) L3MBTL1RAB9AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 GAA 4748/4885L3MBTL1 1817/4885NPSR1 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback